Drugs / Saccharomyces cerevisiae
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05149599 | Mar → Oct 2021 | irritable bowel syndrome | Ziauddin University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Saccharomyces cerevisiae | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05149599 ↗ |
| Modality | Other / unclassified | “Saccharomyces cerevisiae, which is a pro-biotic” NCT05149599 ↗ |